Your current web browser is outdated. For best viewing experience, please consider upgrading to the latest version.

Donation - Other Level

Please use the quantity box to donate any amount you wish. Sign Up to Donate

Contact

Send a question or comment using the form below. This message may be routed through support staff.

Email Article

Password Reset Request

Register


Add a topic or expert to your feed.

Following

Follow Experts & Topics

Stay on top of our work by selecting topics and experts of interest.

Experts
Topics
Project
On The Ground

RSVP

Lecture

The Drug-Pricing Challenge

Tom Coburn, MD Nick Ohnell Fellow, MI; Former U.S. Senator
Tue, Jun 27, 2017

Thank you for your RSVP.

ERROR
Main Error Mesage Here
More detailed message would go here to provide context for the user and how to proceed
ERROR
Main Error Mesage Here
More detailed message would go here to provide context for the user and how to proceed

Manhattan Institute

search
Close Nav

The Drug-Pricing Challenge

SEE ALL EVENTS
Lecture

The Drug-Pricing Challenge: Expanding Access, Accelerating Innovation, Growing the Economy

Tom Coburn, MD Nick Ohnell Fellow, MI; Former U.S. Senator
10:00am—11:30am
Tuesday June 27
Tuesday June 27 2017
PAST EVENT Tuesday June 27 2017

America is the world leader in medical innovation, producing medicines that improve and extend the lives of millions of patients at home and abroad. The biotech industry is also one of the U.S.'s economic crown jewels, generating hundreds of thousands of high-paying jobs and billions of dollars in high-value exports.

Populist solutions to high drug prices, such as price controls and drug importation, will discourage investment in the costly, time-consuming research and development of vital new treatments and cures. Rather than focus on drug prices in a silo, policymakers should explore solutions that ensure that Americans have access to affordable prescription drugs without discouraging innovation. Please join MI's Tom Coburn for a breakfast lecture on the drug-pricing challenge.

Tom Coburn is the Nick Ohnell Fellow at the Manhattan Institute and an advisor to MI's Project FDA. Previously, he represented Oklahoma in the U.S. Senate from 2005 to 2015. A longtime advocate of FDA reform, Dr. Coburn introduced the “Promoting Accountability, Transparency, Innovation, Efficiency, and Timeliness at FDA” act with Senator Richard Burr in 2012. He is the author, most recently, of Smashing the D.C. Monopoly: Using Article V to Restore Freedom and Stop Runaway Government (WND, 2017).

Dr. Coburn—a graduate of Oklahoma State University and the University of Oklahoma Medical School—continued to see patients while serving in Congress. His specializations are family medicine, obstetrics, and allergy.

MEDIA CONTACT

212-599-7000

communications@manhattan-institute.org

TOPICS
Health PolicyDrug Development
Saved!
Close